Rifadin IV NOVAPLUS (Sanofi-Aventis U.S. LLC)
Welcome to the PulseAid listing for the Rifadin IV NOVAPLUS drug offered from Sanofi-Aventis U.S. LLC. This Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sanofi-Aventis U.S. LLC |
| NON-PROPRIETARY NAME: | rifampin |
| SUBSTANCE NAME: | RIFAMPIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-02-01 |
| END MARKETING DATE: | 0000-00-00 |
Rifadin IV NOVAPLUS HUMAN PRESCRIPTION DRUG Details:
| Item Description | Rifadin IV NOVAPLUS from Sanofi-Aventis U.S. LLC |
| LABELER NAME: | Sanofi-Aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 600(mg/10mL) |
| START MARKETING DATE: | 2017-02-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0068-0599_96b46cdb-53d6-496e-9c3b-9234fb297e56 |
| PRODUCT NDC: | 0068-0599 |
| APPLICATION NUMBER: | NDA050627 |
Other RIFAMPIN Pharmaceutical Manufacturers / Labelers:
